BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Adriano M. Pellicelli, Valeria Pace Palitti, Pascal Vignally, Francesca Ceccherini‐Silberstein, Massimo Siciliano, Valerio Giannelli, Alessandra Moretti, Pierluigi Tarquini, Gaetano Scifo, Vincenzo Messina, Antonio Ascione, Antonio Izzi, Massimo Marignani, Cecilia D'Ambrosio, Lucia Fondacaro, Giuseppe M. Ettorre, Pasquale Ialongo, Rodolfo Sacco, Carlo F. Perno, Giorgio Barbarini, Lucia Miglioresi, Roberto Villani, Valeria Cento, Francesca W Chiesara, Loredana Alessio, Luca Fontanella, Barbara Imperatrice, Paola Begini, Giovanni Vennarecci, Angelo Barlattani, Orlando Armignacco, Francesco Di Candilo. Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real‐life studyLiver International 2017; 37(5): 653 doi: 10.1111/liv.13288
2
Feng Su, Lauren A. Beste, Pamela K. Green, Kristin Berry, George N. Ioannou. Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patientsEuropean Journal of Gastroenterology & Hepatology 2017; 29(6): 686 doi: 10.1097/MEG.0000000000000858
3
Iria Rodríguez-Osorio, Purificación Cid, Luis Morano, Ángeles Castro, Marta Suárez, Manuel Delgado, Luis Margusino, Héctor Meijide, Berta Pernas, Andrés Tabernilla, José D. Pedreira, Álvaro Mena, Eva Poveda. Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patientsJournal of Clinical Virology 2017; 88: 58 doi: 10.1016/j.jcv.2017.01.003
4
Chung-Feng Huang, Ming-Lung Yu. Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developmentsExpert Opinion on Pharmacotherapy 2017; 18(17): 1867 doi: 10.1080/14656566.2017.1400010
5
Alessandro Federico, Marcello Dallio, Giuseppe Gerardo Caprio, Ilario de Sio, Gaetano Cotticelli, Pasquale Esposito, Carmelina Loguercio. A Real-Life Study of New Antiviral Therapies in a High Prevalence Geographical Area for Hepatitis C Virus InfectionHepatitis Monthly 2018; (In Press) doi: 10.5812/hepatmon.74224
6
Anca Trifan, Carol Stanciu, Liana Gheorghe, Speranta Iacob, Manuela Curescu, Cristina Cijevschi Prelipcean, Gabriela Stefanescu, Irina Girleanu, Stefan Chiriac, Catalina Mihai, Ciprian Brisc, Adrian Goldis, Ioan Sporea, Egidia Miftode, Simona Bataga, Ion Rogoveanu, Carmen Preda, Florin Alexandru Caruntu, Ana-Maria Singeap. Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or olderMedicine 2017; 96(50): e9271 doi: 10.1097/MD.0000000000009271
7
Sammy Saab, Justin Rheem, Vinay Sundaram. Hepatitis C Infection in the ElderlyDigestive Diseases and Sciences 2015; 60(11): 3170 doi: 10.1007/s10620-015-3717-6
8
F. Conti, S. Brillanti, F. Buonfiglioli, R. Vukotic, M. C. Morelli, C. Lalanne, M. Massari, F. G. Foschi, V. Bernabucci, I. Serio, G. M. Prati, E. Negri, L. Badia, P. Caraceni, P. Muratori, G. Vitale, A. Porro, M. Morotti, G. Mazzella, P. Andreone. Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and olderJournal of Viral Hepatitis 2017; 24(6): 454 doi: 10.1111/jvh.12663
9
Calvin Q. Pan, Vijay Gayam, Charles Rabinovich, Milana Normatov, Bazhena Fidman, Dan Wang, Pavani Garlapati. Efficacy of Direct‐Acting Antivirals for Chronic Hepatitis C in a Large Cohort of Older Adults in the United StatesJournal of the American Geriatrics Society 2020; 68(2): 379 doi: 10.1111/jgs.16206
10
Sammy Saab, Sarah H. Park, Masashi Mizokami, Masao Omata, Alessandra Mangia, Ed Eggleton, Yanni Zhu, Steven J. Knox, Phil Pang, Mani Subramanian, Kris Kowdley, Nezam H. Afdhal. Safety and efficacy of ledipasvir/sofosbuvir for the treatment of genotype 1 hepatitis C in subjects aged 65 years or olderHepatology 2016; 63(4): 1112 doi: 10.1002/hep.28425
11
Yee Tak Hui, Grace L. H. Wong, James Y. Y. Fung, Henry L. Y. Chan, Nancy W. Y. Leung, Sienna D. Liu, Ken Liu, Yiu Keung Ma, David Y. K. But, Wing Yan Mak, Jacky M. C. Chan, Kin Bon Lai, Ching Kong Loo, Annie C. Y. Ng, Moon Sing Lai, Chun Wing Chan, Joulen Y. L. Lau, Tina T. T. Fan, Aric J. Hui, Belsy C. Y. Lam, Wing I. Cheung, Owen T. Y. Tsang, Karen Lam, Lawrence S. W. Lai, Wai Fan Luk, Michael K. K. Li, Wai Cheung Lao, Jodis T. W. Lam, Steven W. C. Tsang, Kam Ngai Kung, Wai Hung Chow, Ronald K. N. Tong, Thomas K. L. Lui, Edwin H. S. Shan, Man Fung Yuen, Vincent W. S. Wong. Territory-wide population-based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong KongLiver International 2018; 38(11): 1911 doi: 10.1111/liv.13926
12
Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Noritomo Shimada, Hiroshi Abe, Keizo Kato, Tomomi Okubo, Taeang Arai, Norio Itokawa, Etsuko Iio, Yasuhito Tanaka, Katsuhiko Iwakiri. Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis CDigestive and Liver Disease 2017; 49(9): 1029 doi: 10.1016/j.dld.2017.04.012
13
Rowena E. Johnston, Mary M. Heitzeg. Sex, Age, Race and Intervention Type in Clinical Studies of HIV Cure: A Systematic ReviewAIDS Research and Human Retroviruses 2015; 31(1): 85 doi: 10.1089/aid.2014.0205